Summary:

- The article discusses a new potential therapy for autoimmune diseases that involves modifying the patient's immune cells to reduce their harmful activity.
- Researchers have found that by targeting a specific protein called PD-1 on T cells, they can suppress the overactive immune response that leads to autoimmune diseases like type 1 diabetes, multiple sclerosis, and rheumatoid arthritis.
- The therapy involves extracting the patient's T cells, engineering them to express less PD-1, and then reinfusing the modified cells back into the patient, which could help restore a healthy immune balance and reduce autoimmune symptoms.